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Chronic Treatment with Lithium Produces 
Supersensitivity to Nicotine 
Steven C. Dilsaver and M. Hariharan 
Introduction 
Dilsaver et al. ( 1988) reported that amitriptyline 
produces supersensitivity of a nicotinic mech- 
anism involved in the regulation of core tem- 
perature. We now present data indicating that 
chronically administered lithium ion also has 
this effect. We will discuss the potential theo- 
retical significance of this finding and review 
other data indicating that treatments for depres- 
sion alter sensitivity to nicotine. 
Methods 
The dependent variable in the experiments re- 
ported here was change in core temperature in 
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response to nicotine (base), 0.40 or 1.0 mgkg 
intraperitoneally (ip) in adult male Sprague- 
Dawley rats housed individually. Core temper- 
ature was telemetrically measured with the model 
VM Mini-Mitter (Mini-Mitter Co., Sun River, 
OR). These instruments, which emit radio waves 
at a rate directly proportional to temperature, 
are implanted into the peritoneal cavity. The rats 
were allowed 5 days to recover prior to starting 
an experiment. A digital frequency counter 
(model 5001 Universal counter-timer; Global 
Specialties, New Haven, CT) connected to an 
AM receiver was used to determine the emission 
rates of each Mini-Mitter. This measurement 
was converted to temperature in degrees Celsius 
(“C) using a linear regression equation derived 
by measuring the emission profile of each in- 
strument in a temperature-controlled water bath 
(Dilsaver et al. 1989). The principles governing 
the use of the Mini-Mitter in psychopharma- 
cological research is described in detail else- 
where (Dilsaver and Alessi 1988). Each of the 
three experiments below required the measure- 
ment of temperature prior to the injection of 
saline or nicotine (at t = 0) and every 10 min 
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thereafter for 120 min. The mean thermic re- 
sponse relative to t = 0 entered into the statis- 
tical analyses. This was calculated by averaging 
the change in core temperature relative to t = 
0, 10, 20, 30 . , 120 min after the injection 
of saline or nicotine. Mean maximum thermic 
response to saline and nicotine are listed for 
completeness and descriptive purposes only. We 
previously reported that these values are rela- 
tively useless for statistical analysis (Dilsaver 
and Alessi 1988). 
Nicotine (base) was purchased from Sigma 
Chemical Company (St. Louis, MO). Lithium 
chloride (LiCl) was obtained from Fisher Sci- 
entific (Pittsburgh, PA). Doses of nicotine and 
lithium refer to the base and salt forms, respec- 
tively. 
Lithium levels were measured by atomic ab- 
sorption spectrophotometry. This assay has in- 
tra- and interassay coefficients of variation of 
4.2% and 5.0%, respectively. Challenges were 
started between 7:00 and 9:00 AM and 9:00 and 
10:00 AM in Experiments 1 and 2, respectively. 
Each subject was challenged with saline (1 ml/kg) 
prior to beginning treatment with lithium. The 
saline challenge provides a baseline against which 
we could compare the thermic response to nic- 
otine. The effect of routine handling and saline 
injection is hyperthermia (Dilsaver and Majchr- 
zak 1989). The animals were then challenged 
(on a separate day) with nicotine (base), 1.0 
mg/kg ip in Experiment 1 and 0.4 mg/kg ip in 
Experiment 2. Treatment with LiCl followed the 
baseline challenge with nicotine. The subjects 
(n = 8) were treated with LiCl, 160 mg/kg ip, 
at 9:00 AM and 5:OO PM for 14 days in Exper- 
iment 1. The last dose of LiCl was given 14 hr 
prior to the third and last challenge with nico- 
tine. LiCl, 120 mg/kg ip, was given at lo:30 
AM and lo:30 PM in Experiment 2 (n = 6) for 
6 days. The last dose was given 10.5 hr prior 
to the secund nicotine challenge. Blood was drawn 
by cardiac puncture for measurement of the 16- 
hr trough lithium level in Experiment 1. Trunk 
blood was collected for measurement of the 
plasma lithium level 12 hr after the last dose in 
Experiment 2. 
A control experiment was designed to asses:, 
the effects of chronic saline injections on the 
thermic responsiveness of rats to nicotine. Mini- 
Mitters were implanted into 11 adult male Spra- 
gue-Dawley rats. The animals were allowed 5 
days to recover prior to being challenged with 
saline (1.0 ml/kg). The following day the rats 
were challenged with nicotine (base), 1 .O mg/kg. 
Following this challenge, each animal received 
saline, 1 ml/kg ip, at 9:00 AM and 5:OO PM for 
14 consecutive days. The thermic response to 
nicotine was reassessed after 7 and 14 days of 
treatment with saline. Saline and nicotine chal- 
lenges began at 9:00 AM. The second and third 
nicotine challenges occurred on the 8th (i.e. ) 
after 7 days of treatment) and 15th (after 14 full 
days of treatment) days of the experiment, re- 
spectively. Challenges occurred 16 hr after the 
preceding injection of saline. The first injection 
of saline on the 8th day followed the completion 
of temperature measurements at 11 :OO AM. 
Data were analyzed by one-way Analysis of 
Variance (ANOVA) for repeated measures, fol- 
lowed by Student’s paired t-tests in Experiments 
1 and 3. Data were analyzed by the Student’s 
paired t-test in Experiment 2. Analyses were 
two-tailed. Measures of variance refer to the 
standard error of the mean (SEM). 
Results 
Experiment 1 
The mean mass of the animals used in this ex- 
periment was 257.5 * 2.4 g. Mean core tem- 
perature at rest prior to challenge with saline 
was 37.4 + 0.22”C. 
The mean peak effect of handling the animals 
and injecting saline was + 0.95 * 0.18”C. The 
mean thermic response to saline was + 0.73 5 
0.16”C. The mean peak thermic responses to 
nicotine before and after 1 and 2 weeks of treat- 
ment were - 1.45 ? 0.30°C, - 1.90 5 0.24“C, 
and - 2.2 & O.l7”C, respectively. The subjects 
exhibited mean thermic responses to nicotine at 
baseline and after 1 and 2 weeks of treatment 
with lithium of -0.60 5 0.24”C, -0.99 t 
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O.l5”C, and - 1.41 + O.l7”C, respectively. 
The mean thermic response to saline differed 
from the initial response to nicotine @ < 0.004, 
t = 4.38, df = 7). A one-way ANOVA for 
repeated measures suggested that the responses 
to nicotine differed across time (df = 2/21, f 
= 4.6, p < 0.025). The thermic response to 
nicotine differed from baseline following 2 weeks 
of treatment (p < 0.03, r = 2.76, df = 7), but 
not after 1 week. 
The mean plasma lithium concentration 16 
hr after the last dose was 0.69 + 0.05 meq/liter. 
Experiment 2 
The mean mass of the rats used in this experi- 
ment was 302.8 + 7.4 g. Mean core temper- 
ature at rest prior to challenge with saline was 
37.9 + O/WC. 
The mean maximum effect of handling the 
animals and injecting saline was + 1.00 + 
0.26”C. The mean thermic response to saline 
was + 0.80 + 0.25”C. The mean maximum 
thermic response to nicotine was -0.92 + 
0.21”C at baseline. The mean thermic response 
to nicotine at baseline was -0.39 + 0.21”C. 
This differed from the response to saline at the 
0.04 level (t = 2.87, df = 5). The sample 
exhibited a mean maximum hypothermic re- 
sponse to nicotine after 1 week of treatment with 
lithium of - 2.27 + 0.29”C. The sample ex- 
hibited a mean thermic response to nicotine of 
- 1.35 + 0.14”C following 6 days of treatment 
with lithium. This differed from the response at 
baseline (p < 0.03, t = 3.15, df = 5). 
The mean 12-hr trough lithium concentration 
was 1.44 + 0.28 meq/liter. 
Experiment 3 
The mean mass of the sample used in this ex- 
periment was 267.3 + 2.4 g. The mean core 
temperature of the sample prior to challenge 
with saline was 37.1 f 0.05”C. 
The mean maximum thermic response to 
handling the animals and injecting saline injec- 
tion was +0.84 f 0.07”C. The mean thermic 
response to saline was +0.72 f 0.05”C. The 
sample exhibited mean maximum therm& re- 
sponses to nicotine of - 1.2 f O.O9”C, -0.92 
+ O.O9”C, and -0.73 + 0.09”C in response 
to nicotine challenges 1, 2, and 3, respectively. 
The sample exhibited mean thermic responses 
to nicotine of -0.47 t O.O8”C, -0.19 2 
OXWC, and -0.18 + 0.07”C at baseline and 
after 1 and 2 weeks of treatment with saline, 
respectively. These means differed (df = 2/20, 
f = 6.5, p < 0.01). The hypothermic response 
to nicotine was blunted after 1 (p < 0.05, t = 
2.31, df = 10) and 2 (p < 0.05, I = 2.48, df 
= 10) week of treatment relative to baseline. 
Discussion 
These data indicate that lithium, similar to ami- 
triptyline, produces supersensitivity to nicotine. 
Those rats receiving the lower dose of LiCl had 
the higher mean plasma lithium concentration. 
This is partially attributable to the time at which 
blood was collected after the last dose. A more 
important factor may be biological heteroge- 
neity. Rodents and humans vary in the plasma 
lithium level attained at a fixed dose. For ex- 
ample, some patients reach a steady-state trough 
plasma concentration of 1.0 meq/liter when 
treated with 600 mg of lithium carbonate daily, 
whereas others may require 1200-l 800 mg to 
reach this level. Interestingly, the sample with 
the higher plasma lithium level became super- 
sensitive to nicotine sooner. The development 
of supersensitivity to nicotine could be both time- 
and drug-level dependent. 
Nicotine promotes the release of dopamine 
in the nigrostriatal and mesolimbic tracts (An- 
dersonn et al. 1981) and triggers the release of 
norepinephrine in the hypothalamus (Westfall 
1973). Activation of nicotinic receptors in pe- 
ripheral ganglia increases the activity of tyrosine 
hydroxylase (Thoenen et al. 1973). Thus, the 
findings are consistent with the hypothesis that 
lithium potentiates aminergic mechanisms via 
effects on nicotinic mechanisms. This is con- 
sistent with the capacity of lithium to augment 




The observation that twice-daily injections of 
saline were associated with a blunting of the 
hypothermic response to saline is intriguing. This 
is a new finding. The routine handling of an 
animal and an accompanying injection are 
stressors (Dilsaver and Majchrzak 1989). Blunt- 
ing of the hypothermic response to nicotine may 
be due to this stress. For our immediate pur- 
poses, it is essential to note that twice-daily 
injections of saline did not enhance the respon- 
siveness of animals to nicotine. This result would 
have called into question our claim that twice- 
daily injections of LiCl produces supersensitiv- 
ity to nicotine. 
We have reported that chronic treatment with 
fluoxetine (Dilsaver and Davidson 1987), phe- 
nelzine (Dilsaver and Hariharan 1989), desipra- 
mine (Dilsaver and Hariharan 1988), and bright 
artificial light (Dilsaver and Majchrzak 1988; 
Dilsaver 1988) produce subsensitivity to nico- 
tine. We established that phenelzine and desi- 
pramine do not accelerate the metabolism of 
nicotine. Lithium is excreted exclusively by the 
kidney. There is no reason to suppose that it 
alters the metaboloism of nicotine. There is no 
a priori reason to suppose that bright light alters 
hepatic enzymatic activity. Thus, six of the 
treatments studied either produced supersensi- 
tivity or subsensitivity to nicotine, and in at least 
four instances, pharmacokinetic effects do not 
appear to account for this. 
The thermic responsiveness of animals of the 
same strain to nicotine is subject to two primary 
sources of variance. We previously emphasized 
that due to relatively great intersample variations 
in thermic responsiveness to agonists, experi- 
mental designs using each animal as its own con- 
trol arc preferred (D&aver and Alessi 1988). The 
responsiveness of each rat to nicotine week after 
week is reasonably similar. This is highlighted 
by our finding that weekly injections of nicotine 
at 1 .O mg/kg does not alter the mean hypothermic 
response of a sample (Dilsaver et al. 1988). Fi- 
nally, the source of nicotine used in the chal- 
lenges may be important. Using a high-pressure 
liquid chromatography assay (Hariharan et al. 
1987), we demonstrated that nicotine (base) de- 
grades as it ages when routinely stored. 
Lithium, similar to antidepressant treatments 
of several classes, alters a nicotinic mechanism. 
The nicotinic effects of treatments for affective 
disorders may be relevant to their side effect 
profiles or mechanisms of action. Obviously, 
much more serious research is needed in this 
area. 
The authors wish to thank Mr. Duane Flemmer for his 
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Plasma Nor~pinep~n~ Response to Exercise in 
Bulimia, Anorexia Nervosa, and Controls 
Karl M. Pirke, Matbias Eckert, Bettina Ofers, Gerhard Goebl, 
Barbara Spyra, Ulrich Schweiger, Reinhard J. Tuschl, and 
Manfred M. Fichter 
Introduction 
Altered function of the sympathetic nervous sys- 
tem has been observed in anorexia nervosa and 
bulimia. The excretion of me~oxy-hy~oxy- 
phenylglycol sulfate in urine (MOPEG sulfate) 
was found to be decreased in anorexia nervosa 
(Halmi et al. 1979; Abraham et al. 198 1; Gerner 
and Gwirtsman 1981) and in bulimia (Philipp 
et al. 1988b). Reduced basal plasma concentra- 
tions and an impaired orthostatic response were 
observed in both eating disorders (Gross et al. 
1979; Heufelder et al. 1985). Reduced concen- 
trations of norepinephrine metabolites were 
measured in the cerebrospinal fluid of anorectic 
patients (Ebert et al. 1984). The increase of 
plasma no~pinep~ne after standardized test 
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meals was significantly reduced in anorectic and 
in normal weight bulimics (Puke et al. 1988a). 
The number of alpha-Z-receptors on platelets is 
increased (Luck et al. 1983; Heufelder et al. 
1985). No~pinep~ne regulates vasculatory, 
cardiac, ventilatory, and metabolic adaptation 
to exercise. Nude1 et al. (1984) showed signif- 
icantly lower increases in norepinephrine con- 
centration after maximal ergometric exercise in 
anorectic patients than in controls. To our 
knowledge, no data have so far been reported 
for bulimic patients. 
Methods 
Fourteen patients with buhmia, mean age 24.0 
+ 4.0 years, 9 patients with anorexia nervosa, 
mean age 22.9 f 3.9 years, and 11 healthy 
controls, mean age 23.8 ?I 3.3 years, volun- 
teered for the study. Patients were all female 
and participated in an inpatients treatment pro- 
gram at the Psychoso~~~h Klinik Roseneck. 
Diagnosis was made according to the DSM-Hi 
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